EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
75 hedge funds and large institutions have $55.5M invested in Eagle Pharmaceuticals, Inc. in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 41 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
75
Holding in Top 10
–
Calls
$5.66M
Puts
–
Top Buyers
| 1 | +$5.59M | |
| 2 | +$3.94M | |
| 3 | +$971K | |
| 4 |
RC
RBF Capital
San Francisco,
California
|
+$717K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$145K |
Top Sellers
| 1 | -$3.05M | |
| 2 | -$1.02M | |
| 3 | -$996K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$897K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$693K |